Home » Psychology news » Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke
Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke
October 25, 2013 by NewsBot
The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).
